In agreement with our findings associating G-CSF levels with a good prognosis, previous studies demonstrated that the administration of G-CSF increased the number of lymphocytes, T-cells, thus improving the clinical symptoms in severe COVID-19 patients (25). Here, CSF3 is linked to COVID-19.